BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3943748)

  • 1. A review of second-look laparotomy for ovarian cancer.
    Cain JM; Saigo PE; Pierce VK; Clark DG; Jones WB; Smith DH; Hakes TB; Ochoa M; Lewis JL
    Gynecol Oncol; 1986 Jan; 23(1):14-25. PubMed ID: 3943748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-look laparotomy after chemotherapy in the management of ovarian malignancy.
    Smirz LR; Stehman FB; Ulbright TM; Sutton GP; Ehrlich CE
    Am J Obstet Gynecol; 1985 Jul; 152(6 Pt 1):661-8. PubMed ID: 4040706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy.
    Rubin SC; Hoskins WJ; Saigo PE; Chapman D; Hakes TB; Markman M; Reichman B; Almadrones L; Lewis JL
    Gynecol Oncol; 1991 Aug; 42(2):137-41. PubMed ID: 1894172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
    Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
    Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma.
    Eifel PJ; Gershenson DM; Delclos L; Wharton JT; Peters LJ
    Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):1013-8. PubMed ID: 1917596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of second-look laparotomy in the management of patients with stage II, III and IV ovarian cancers following chemotherapy with cisplatin, adriamycin and cyclophosphamide.
    Kirwan PH; Naftalin NJ; Khanna S; Aukett RJ
    Br J Obstet Gynaecol; 1986 Jun; 93(6):629-33. PubMed ID: 3730331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
    Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
    Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin-containing versus cisplatin-free adjuvant chemotherapy in ovarian carcinoma. Results after second-look laparotomy.
    Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
    Oncology; 1990; 47(2):109-11. PubMed ID: 2314822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of second-look laparotomy in the management of patients with ovarian epithelial malignancies.
    Podczaski ES; Stevens CW; Manetta A; Whitney CW; Larson JE; Mortel R
    Gynecol Oncol; 1987 Oct; 28(2):205-14. PubMed ID: 3666578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; GĂ©rard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential.
    Barakat RR; Benjamin I; Lewis JL; Saigo PE; Curtin JP; Hoskins WJ
    Gynecol Oncol; 1995 Dec; 59(3):390-3. PubMed ID: 8522261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced ovarian cancer: long-term results following chemotherapy and second-look laparotomy.
    Davidson NG; Khanna S; Kirwan P; Bircumshaw D
    Gynecol Oncol; 1990 Dec; 39(3):295-9. PubMed ID: 2258074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Place of second-look laparotomy after 18 courses of chemotherapy in epithelial ovarian cancer.
    Ngan HY; Wong LC; Ma HK
    Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):52-4. PubMed ID: 2562603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
    Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
    Friedman RL; Eisenkop SM; Wang HJ
    Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
    Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
    J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of second-look laparotomy in treatment of epithelial ovarian cancer.
    McCusker MC; Hoffman JS; Curry SL; Koulos JP; Gondos B
    Gynecol Oncol; 1987 Sep; 28(1):83-8. PubMed ID: 3653773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies of second-look operations (SLO) in ovarian cancer].
    Yuzawa H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1310-6. PubMed ID: 2658822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings.
    Rubin SC; Randall TC; Armstrong KA; Chi DS; Hoskins WJ
    Obstet Gynecol; 1999 Jan; 93(1):21-4. PubMed ID: 9916949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.